Notaflu Lemon Oil Nasal
Lemon
Rapha Health Network International
Human Otc Drug
NDC 78527-003Notaflu Lemon Oil Nasal also known as Lemon is a human otc drug labeled by 'Rapha Health Network International'. National Drug Code (NDC) number for Notaflu Lemon Oil Nasal is 78527-003. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Notaflu Lemon Oil Nasal drug includes Lemon Oil - 1 [hp_X]/mL . The currest status of Notaflu Lemon Oil Nasal drug is Active.
Drug Information:
| Drug NDC: | 78527-003 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Notaflu Lemon Oil Nasal |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Lemon |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Rapha Health Network International |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Spray |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | LEMON OIL - 1 [hp_X]/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 16 Sep, 2013 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 19 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | RAPHA HEALTH NETWORK INTERNATIONAL
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0816957010524
|
| UPC stands for Universal Product Code. |
| UNII: | I9GRO824LL
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 78527-003-01 | 30 mL in 1 BOTTLE, SPRAY (78527-003-01) | 16 Sep, 2013 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Product Elements:
Notaflu lemon oil nasal lemon sea salt water lemon oil lemon oil
Indications and Usage:
Notaflu is a nasal spray formulated to support good nasal and sinus health in adults and children. notaflu is a proprietary blend of all natural ingredients. it does not contain any synthetic preservatives or antibacterial agents notaflu has no known contraindications o side effects.
Warnings:
Warnings: keep out of reach of children do not exceed recommended dosage please consult with your physician if you are undergoing treatment form medical condition or if you are pregnant or lactating.
Dosage and Administration:
Directions: adults and children 6 to under 12years of age (with adult supervision) 2 sprays in each nostril 3 times per day. children under 6 yearsof age: ask a doctor.
Package Label Principal Display Panel:
Package labeling: label